Matrix
Sponsor responsibility matrix for Australian clinical trials
A responsibility matrix is one of the most useful documents for an overseas company appointing an Australian local sponsor.
It shows who owns each sponsor-side activity and prevents the local sponsor role from being treated as a formality.
Short answer
A sponsor responsibility matrix records which party is responsible for each Australian sponsor function, what remains with the overseas company, and how sites, investigators, approving authorities, and other providers fit into the trial model.
Purpose
The matrix turns the sponsor model into operating detail.
Overseas teams often understand that Australia needs a local sponsor but underestimate the operational clarity required behind that appointment.
A matrix helps align the protocol, pathway, safety model, insurance, site arrangements, contracts, records, and study governance before the Australian clinical trial starts.
Timing
Build it before startup gets busy.
The matrix should be drafted before site activation, CTN or CTA activity, contracting, and safety reporting processes are locked in. It is much harder to correct blurred responsibility boundaries after the trial is underway.
Practical use
Use it as a discussion tool, not a decorative appendix.
The matrix should be clear enough for clinical, regulatory, quality, legal, safety, and operations teams to understand who does what. It should also be kept current if sites, vendors, product information, or the protocol changes.
Practical matrix
Example matrix areas
The exact matrix should be tailored for each clinical trial. These categories are a useful starting point for overseas sponsors.
| Area | Usually needs Australian sponsor visibility | Usually needs overseas sponsor input |
|---|---|---|
| Pathway | CTN or CTA activity, variations, completion, and TGA-facing sponsor records. | Product evidence, protocol rationale, risk profile, and pathway strategy. |
| Approvals | Sponsor-side view of HREC and approving authority requirements. | Protocol, investigator information, site list, and study documentation. |
| Safety | Australian reporting interfaces, escalation paths, and sponsor oversight. | Global safety database, product safety information, and medical review inputs. |
| Product supply | Visibility of supply model and Australian sponsor implications. | Manufacturing, labelling, import, storage, accountability, and return or disposal model. |
| Records | Australian sponsor records and evidence of sponsor oversight. | Master documents, amendments, monitoring outputs, reports, and global trial records. |
Common questions
Questions overseas teams usually ask
Is a responsibility matrix legally required?
The specific format may vary, but the underlying need for clear allocation and oversight of sponsor responsibilities is fundamental to a credible sponsor arrangement.
Who should review the matrix?
Clinical operations, regulatory, safety, quality, legal, and sponsor representatives should all be able to understand and work from it.
Can Clintrail help create the matrix?
Clintrail can work through the Australian sponsor-role split with the overseas company so the local sponsor arrangement is clear before startup progresses.
Source context
Grounded in Australian clinical trial requirements.
These pages are written for planning clarity. They do not replace legal, tax, regulatory, insurance, ethics, or clinical operations advice for a specific trial.
Related pages
Continue the sponsor-structure research
CTN vs CTA in Australia for overseas sponsors
A practical guide for overseas sponsors comparing Australia's CTN and CTA pathways and understanding where the Australian local sponsor fits.
Australian clinical trial sponsor responsibilities
What overseas sponsors need to understand about the Australian clinical trial sponsor role, sponsor oversight, approvals, safety, records, and responsibility allocation.
Medical device trials in Australia with a local sponsor
How overseas medical device companies can use an Australian local sponsor for Australian clinical trials, including device-specific sponsor considerations.
IVD and diagnostics trials in Australia with a local sponsor
How overseas diagnostics and IVD companies can structure Australian clinical performance or diagnostics studies with an Australian local sponsor.
Next step
Need an Australian local sponsor?
Send through a short description of the clinical trial and your planned Australian activity. We will review it and get back to you soon.